These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9681456)

  • 1. Voltammetric studies on mechanisms of dopamine efflux in the presence of substrates and cocaine from cells expressing human norepinephrine transporter.
    Chen N; Trowbridge CG; Justice JB
    J Neurochem; 1998 Aug; 71(2):653-65. PubMed ID: 9681456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cocaine acts as an apparent competitive inhibitor at the outward-facing conformation of the human norepinephrine transporter: kinetic analysis of inward and outward transport.
    Chen N; Justice JB
    J Neurosci; 1998 Dec; 18(24):10257-68. PubMed ID: 9852563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cationic modulation of human dopamine transporter: dopamine uptake and inhibition of uptake.
    Chen N; Trowbridge CG; Justice JB
    J Pharmacol Exp Ther; 1999 Sep; 290(3):940-9. PubMed ID: 10454463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human norepinephrine transporter kinetics using rotating disk electrode voltammetry.
    Burnette WB; Bailey MD; Kukoyi S; Blakely RD; Trowbridge CG; Justice JB
    Anal Chem; 1996 Sep; 68(17):2932-8. PubMed ID: 8794928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of cocaine effect on dopamine clearance in the core and shell of the nucleus accumbens of dopamine transporter knock-out mice.
    Budygin EA; John CE; Mateo Y; Jones SR
    J Neurosci; 2002 May; 22(10):RC222. PubMed ID: 12006604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological properties of the naturally occurring Ala(457)Pro variant of the human norepinephrine transporter.
    Paczkowski FA; Bönisch H; Bryan-Lluka LJ
    Pharmacogenetics; 2002 Mar; 12(2):165-73. PubMed ID: 11875370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of blockade of the noradrenaline carrier to the increase of extracellular dopamine in the rat prefrontal cortex by amphetamine and cocaine.
    Tanda G; Pontieri FE; Frau R; Di Chiara G
    Eur J Neurosci; 1997 Oct; 9(10):2077-85. PubMed ID: 9421168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual-electrode voltammetry of catecholamine transport: simultaneous monitoring of uptake and efflux.
    Reed B; Chen N; Justice JB
    J Neurosci Methods; 2003 Jun; 126(2):127-35. PubMed ID: 12814837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of serine mutations in transmembrane domain 7 of the human norepinephrine transporter on substrate binding and transport.
    Danek Burgess KS; Justice JB
    J Neurochem; 1999 Aug; 73(2):656-64. PubMed ID: 10428062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biogenic amine flux mediated by cloned transporters stably expressed in cultured cell lines: amphetamine specificity for inhibition and efflux.
    Wall SC; Gu H; Rudnick G
    Mol Pharmacol; 1995 Mar; 47(3):544-50. PubMed ID: 7700252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sodium-dependent norepinephrine-induced currents in norepinephrine-transporter-transfected HEK-293 cells blocked by cocaine and antidepressants.
    Galli A; DeFelice LJ; Duke BJ; Moore KR; Blakely RD
    J Exp Biol; 1995 Oct; 198(Pt 10):2197-212. PubMed ID: 7500004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effect of structural modification of human dopamine transporter on the inward and outward transport of dopamine.
    Chen N; Justice JB
    Brain Res Mol Brain Res; 2000 Feb; 75(2):208-15. PubMed ID: 10686341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines.
    Morón JA; Brockington A; Wise RA; Rocha BA; Hope BT
    J Neurosci; 2002 Jan; 22(2):389-95. PubMed ID: 11784783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tyrosine residue 271 of the norepinephrine transporter is an important determinant of its pharmacology.
    Paczkowski FA; Bryan-Lluka LJ
    Brain Res Mol Brain Res; 2001 Dec; 97(1):32-42. PubMed ID: 11744160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LLC-PK(1) cells stably expressing the human norepinephrine transporter: A functional model of carrier-mediated norepinephrine release in protracted myocardial ischemia.
    Smith NC; Levi R
    J Pharmacol Exp Ther; 1999 Nov; 291(2):456-63. PubMed ID: 10525059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine release and uptake dynamics within nonhuman primate striatum in vitro.
    Cragg SJ; Hille CJ; Greenfield SA
    J Neurosci; 2000 Nov; 20(21):8209-17. PubMed ID: 11050144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sodium- and chloride-dependent, cocaine-sensitive, high-affinity binding of nisoxetine to the human placental norepinephrine transporter.
    Jayanthi LD; Prasad PD; Ramamoorthy S; Mahesh VB; Leibach FH; Ganapathy V
    Biochemistry; 1993 Nov; 32(45):12178-85. PubMed ID: 8218295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of catecholamine uptake blockers in the caudate-putamen and subregions of the medial prefrontal cortex of the rat.
    Mazei MS; Pluto CP; Kirkbride B; Pehek EA
    Brain Res; 2002 May; 936(1-2):58-67. PubMed ID: 11988230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ion coupling stoichiometry for the norepinephrine transporter in membrane vesicles from stably transfected cells.
    Gu HH; Wall S; Rudnick G
    J Biol Chem; 1996 Mar; 271(12):6911-6. PubMed ID: 8636118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition by neuromuscular blocking drugs of norepinephrine transporter in cultured bovine adrenal medullary cells.
    Uryu K; Minami K; Yanagihara N; Hara K; Toyohira Y; Izumi F; Shigematsu A
    Anesth Analg; 2000 Sep; 91(3):546-51. PubMed ID: 10960373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.